hypothiocyanite ion has been researched along with aztreonam in 1 studies
| Studies (hypothiocyanite ion) | Trials (hypothiocyanite ion) | Recent Studies (post-2010) (hypothiocyanite ion) | Studies (aztreonam) | Trials (aztreonam) | Recent Studies (post-2010) (aztreonam) |
|---|---|---|---|---|---|
| 97 | 7 | 24 | 1,564 | 234 | 355 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coutermarsh, B; Moreau-Marquis, S; Stanton, BA | 1 |
1 other study(ies) available for hypothiocyanite ion and aztreonam
| Article | Year |
|---|---|
Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells.
Topics: Anti-Bacterial Agents; Aztreonam; Biofilms; Cells, Cultured; Colony Count, Microbial; Drug Combinations; Drug Synergism; Epithelial Cells; Humans; Lactoferrin; Microbial Viability; Pseudomonas aeruginosa; Thiocyanates; Tobramycin | 2015 |